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ABS TRACT
Background and objectives: Pre-eclampsia often has detrimental health effects for pregnant women and
their fetuses, but whether exposure in the womb has long-term health-consequences for children as they
grow up remains poorly understood. We assessed overall morbidity of children following exposure to
either mild or severe pre-eclampsia up to 30 years after birth and related disease risks to duration of
exposure, i.e. the time from diagnosis to delivery.
Methodology: We did a registry-based retrospective cohort study in Denmark covering the years 1979–
2009, using the separate diagnoses of mild and severe pre-eclampsia and the duration of exposure as
predictor variables for specific and overall risks of later disease. We analysed 3 537 525 diagnoses for 14
disease groups, accumulated by 758 524 singleton children, after subdividing deliveries in six gesta-
tional age categories, partialing out effects of eight potentially confounding factors.
Results: Exposure to mild pre-eclampsia appeared to have consistent negative effects on health later in
life, although only a few specific disease cases remained significant after corrections for multiple testing.
Morbidity risks associated with mild pre-eclampsia were of similar magnitude as those associated with
severe pre-eclampsia. Apart from this overall trend in number of diagnoses incurred across disease
groups, hazard ratios for several disorders also increased with the duration of exposure, including
disorders related to the metabolic syndrome.
Conclusions and implications: Maternal pre-eclampsia has lasting effects on offspring health and dif-
ferences between exposure to severe and mild pre-eclampsia appear to be less than previously
assumed. Our results suggest that it would be prudent to include the long-term health prospects of
children in the complex clinical management of mild pre-eclampsia.
original
research
article
53
 The Author(s) 2017. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health. This is an Open
Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloaded from https://academic.oup.com/emph/article-abstract/2017/1/53/2977676
by Kobenhavns Universitets user
on 07 May 2018
KEYWORDS : pre-eclampsia; public health; child morbidity; exposure in utero; metabolic syndrome
INTRODUCTION
Pre-eclampsia is part of a pregnancy specific syn-
drome defined clinically by new-onset hypertension
and multi-organ failure; it complicates 5–8% of all
pregnancies worldwide with potentially life threaten-
ing consequences for both mothers and children [1].
Pre-eclampsia mainly affects the liver, kidneys and
central nervous system of expectant mothers and
the symptoms may include, in addition to hyperten-
sion and proteinuria (protein-levels in urine exceed-
ing 0.3 g/24 h), headaches and cerebral or visual
disturbances which can progress into convulsions
if the disorder proceeds to eclampsia.
There is general consensus on the optimal expect-
ant management of severe pre-eclampsia before 34
weeks gestation [2, 3], where the risk of fetal prema-
turity is balanced against maternal risk of further
progression of the disorder [2]. From 37 weeks on-
wards, prematurity of the baby is a minor concern
and delivery is therefore usually induced when pre-
eclampsia is severe and the same criterion is often
also used for mothers with mild pre-eclampsia [4].
However, for gestations of intermediate duration
(34–36 weeks) delivery decisions depend on individ-
ual obstetric management assessments, which may
be informed by ongoing randomized clinical trials
[5]. As immediate risks for damage to maternal
health are fewer, pregnancies with mild pre-
eclampsia are often subject to surveillance and
carried to term when possible, both in Denmark
and many other affluent countries.
The etiology of pre-eclampsia remains largely un-
known and many have attempted to elucidate why a
disease that is both damaging for mother and child
does in fact exist. Pre-eclampsia has been shown to
be long-term detrimental for maternal health as it in-
creases risk of cardio-vascular diseases and type-2
diabetes later in life and incurs an increased likeli-
hood of developing again in later pregnancies [6–8].
The standard medical interpretation of pre-eclampsia
is that it represents an early maternal immunological
maladaptation to ongoing fetal implantation, trigger-
ing a systemic response where the maternal endothe-
lium produces the symptoms of hypertension and
proteinuria [9]. This has been referred to as an ex-
ample of the Goldilock principle, where the fetal im-
plantation and inflammation signals cause
symptoms when responses are too high or too low,
but sustain normal pregnancies when in-between
[10].
Evolutionarily hypotheses have been proposed as
well to explain the conundrum of why pre-eclampsia
has not been removed by natural selection despite the
potentially severe impact on female reproductive suc-
cess, especially in populations with natural birth rates
before medical intervention and management was
possible. First, pre-eclampsia has been suggested to
be a by-product of selection for large brain size in the
hominin lineage [11]. Endowing fetuses with a large
brain is energetically expensive and has been
associated with exceptionally deep trophoblasts inva-
sion during implantation and early placenta develop-
ment. If this early process partly fails the fetus will not
receive sufficient maternal resources and may some-
how induce elevated maternal blood pressure to com-
pensate, leading to a higher likelihood of pre-
eclampsia. According to this hypothesis, sufficient
brain size at birth is assumed to be so important for
future reproductive success that it precluded pre-
eclampsia from disappearing from ancestral human
populations [11, 12]. However, recent evidence for
pre-eclampsia in chimpanzees appears to contradict
this hypothesis [13, 14].
Alternatively, pre-eclampsia may be the result of
an imbalance in the tug-of-war between paternal and
maternal interests in resource provisioning to an
unborn child. Trivers [15] recognized that maternal
and offspring interests in resource provisioning are
only partly aligned, so that offspring will tend to ex-
press traits to extract more resources than mothers
are selected to provide when their life-time repro-
ductive success is maximized by sharing resources
equally amongst current and future offspring. Haig
[16, 17] extended parent-offspring conflict theory by
distinguishing between general age-dependent
gene expression serving maternal or offspring inter-
ests, and genetic parental antagonism based on a
special subset of imprinted genes affecting embryo
and fetal provisioning in opposite directions. These
imprinted genes are known from the placenta,
where the paternal copy may be expressed and the
maternal copy silenced or vice versa, as, for example,
in IGF2 and its receptor [18]. Effects of such im-
printed genes have been referred to as padumnal
versus madumnal [19] or as patrigenic versus
matrigenic [20].
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Both parent-offspring theory in the sense of Trivers
and parental antagonism in the sense of Haig are
affected by the probability of parental promiscuity in
the population, but in different ways. A higher prob-
ability of future maternal offspring being half siblings
aggravates parent-offspring conflict because, from an
offspring’s perspective, the relatedness difference
between self (100%) and future full- (50%) or half-
siblings (25%) is 2:1 and 4:1, respectively. However,
when both parents are diploid, parental antagonism
should be absent in populations with 100% monog-
amy. Paternal imprinting (silencing of maternal gene
copies) is thus expected to be driven by the popula-
tion-wide probability of serial monogamy or promis-
cuity, which imposes selection for compensating
maternal imprinting (silencing of paternal gene
copies) at other loci [16, 18, 21]. The parental antag-
onism hypothesis has gained considerable credibility
in recent years because a number of imprinted genes
with opposite effects on placental resource provision-
ing have been documented [22, 23]. In such cases,
paternally imprinted genes have phenotypic effects to
increase embryo or fetal provisioning, whereas ma-
ternally imprinted genes express phenotypes to resist
such manipulation. As maternal blood pressure dur-
ing pregnancy increases offspring provisioning, pre-
eclampsia may thus be a byproduct consequence of
this tug of war. However, we would expect maternal
imprints to have evolved higher levels of control if
pregnancy-related hypertension only had negative ef-
fects on maternal and offspring fitness.
In an earlier study, we provided a partial answer to
the question of why pre-eclampsia may have been
maintained in ancestral human populations by
showing that mortality and morbidity in children of
mothers with slightly elevated blood pressure in the
first trimester were significantly lower relative to con-
trol pregnancies without any hypertension diag-
noses. However, these correlations reversed when
hypertension diagnoses continued during the se-
cond and third trimester [24]. This confirmed earlier
smaller-scale studies that had pooled gestational
hypertension diagnoses to show that modest hyper-
tension may improve neonatal health provided it
does not persist [25, 26]. These results suggest that
padumnal demands are beneficial for offspring
health provided madumnal compensation gains
overall control so placentas develop normally. Pre-
eclampsia could then be conceptualized as a nega-
tive byproduct when padumnal/madumnal balance
is not achieved and trophoblast invasion remains
underdeveloped, so that hypertension is the only
mechanisms for paternally imprinted genes to se-
cure additional provisioning in later trimesters [16,
17, 27]. When balanced, tug-of-war conflicts are ex-
pected to result in children of average size and
weight at birth and above average health after birth,
while imbalances to either side may produce babies
that are small or large for gestational age with higher
likelihoods of physical and mental health problems
later in life [24, 28].
In the present study we used the same Danish
public health data to address a complementary
question that has so far remained unexplored,
asking whether the duration of exposure to maternal
pre-eclampsia may have lasting consequences for
offspring health. This question is of interest both
for the clinical management of pre-eclampsia, and
evolutionarily because it explores the degree to
which hypertension related disorders during preg-
nancy have a common cause as expected when
unbalanced parental conflict drives the continued
existence of these pregnancy disorders. Because re-
cent research has indicated that the umbilical cord in
pre-eclamptic pregnancies has increased athero-
sclerosis of the endothelium at birth [29], there are
also proximate reasons for doing a large-scale study
focusing on later child health, particularly to evaluate
whether offspring cardiovascular diagnoses would
correlate with the time from onset of maternal
preeclampsia symptoms to delivery. We therefore
designed a retrospective cohort study investigating
all disease diagnoses except accidents from birth
until 30 years of age in a large cohort of Danish chil-
dren delivered after pregnancies with mild or severe
pre-eclampsia versus normotensive controls, using
gestational age and duration of diagnosed pre-
eclampsia as predictor variables.
METHODS
Study population
We linked data from the Civil Registration System
with the Danish National Patient Registry, Fertility
Database, Birth Registry and Cause of Death
Registry, via PNR numbers (anonymized personal
identification numbers, CPR-numbers). We ex-
tracted information on all singleton births from
1 January 1979 to 31 December 2009, yielding
1 872 192 births by 1 004 129 mothers. We excluded
births with missing values for one or more key vari-
ables such as PNR number, birth weight, birth
length, gestational age, maternal birth-related
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diagnoses such as gestational diabetes, sequential
births with short birth interval, child PNR numbers
matching more than one mother, and pre-pregnancy
diagnoses that could directly affect the risk of pre-
eclampsia (any type of diabetes, purpura, circulatory
diseases such as chronic hypertension, hypotension
and ischemic heart disease, and insufficient kidney
and liver function), which gave us a final cohort of
758 524 births by 413 594 mothers. Possible causes
and consequences of caesarean sections could not
be included in our analyses because they were not
registered before 1996 and registration did not be-
come diagnose-specific until 2004. The available
data allowed us to extract information on all off-
spring diagnoses yielding 3 537 525 diagnoses
across the maximally 30 years of follow-up.
Offspring morbidity thus covered all diagnoses
received through hospitalization and ambulant
visits from birth to end of follow-up time (31
December 2009) with a minimum of 4 years of fol-
low-up time.
In Denmark, medical services are free of charge
and all residents have access to the same health care.
This also applies to pregnant women, who are by de-
fault enrolled in a program with regular visits to a
midwife and general practitioner, fetal ultrasound
scans, advice on how to lose weight when deemed
desirable, encouragement to give up smoking, etc.
When registered as patients, all mothers and off-
spring in our study receive a medical evaluation and
a diagnose code when referred or admitted to the
hospital. These diagnoses are all registered (follow-
ing ICD-8 from 1979 to 94 and thereafter ICD-10) in a
hierarchical system with main disease categories,
subcategories and further subcategories where ap-
propriate. In our present study, morbidity refers to
all diagnoses grouped primarily according to the 14
major disease groups defined by the WHO (see
Supplementary Table S1) excluding only diagnoses
related to accidents (injuries or other external causes:
DS00-DZ99, DX60-DY09), which were not expected
to have any relations to maternal pre-eclampsia.
Diagnoses, exclusions and gestation length
categories
For statistical analyses, we categorized births into
three groups based on diagnoses of pre-eclampsia
(see Supplementary Table S1): mild pre-eclampsia
(ICD 8/ICD 10 codes 63703/DO140), severe pre-
eclampsia (ICD 8/ICD 10 codes 63704/DO141)
and unexposed (controls). The Danish National
Patient register has been validated by the Danish
Health Authorities to ensure consistency of diag-
noses for research across all years in the registries.
These validations have investigated the diagnostic
criteria behind all diagnoses from 1977 to 2010 and
evaluated the use of both ICD-8 and ICD-10 codes to
ensure that they are comparable. In this process the
diagnoses of pre-eclampsia were matched between
ICD-8 and ICD-10 codes so they corresponded to the
set of diagnostic criteria in the guidelines from the
Danish Health Authorities.
To ensure that data for fetuses exposed to both
mild and severe pre-eclampsia would not be con-
founded across categories, we excluded women in
the mild pre-eclampsia group who progressed into
severe pre-eclampsia during the same pregnancy.
We also excluded a residual group consisting of
women diagnosed with unspecified pre-eclampsia
(ICD 8 code 63709 and ICD 10 code DO149) due
to inconsistencies in the diagnostic criteria, and
women with any form of pre-eclampsia that pro-
gressed into eclampsia (ICD 8 code 63719 and ICD
10 code DO15) or the post-partum disease HELLP
syndrome (ICD 8 code 63799 and ICD 10 code
DO142). The final pre-eclampsia sample thus con-
sisted of 28 471 births (23 920 with mild pre-
eclampsia and 4551 with severe pre-eclampsia),
while the unexposed cohort consisted of 704 013
births without any of these hypertensive disorders
(Table 1).
We stratified births into six categories based on
gestational length: extremely preterm 20–27 weeks,
very preterm 28–33 weeks, preterm 34–36 weeks,
early term 37–38 weeks, full term 39–40 weeks and
post-term 41–44 weeks. Due to low sample sizes in
week 20–27 (unexposed: 391, mild pre-eclampsia: 3,
severe pre-eclampsia: 48) we only included the results
from this category in the supplementary material on-
line and we refrained from detailed interpretations of
the 28–33 weeks delivery cohort (unexposed: 4663,
mild pre-eclampsia: 181, severe pre-eclampsia: 683)
for the same reasons.
Statistics and analyses
We used Cox proportional-hazard regression (R ver-
sion 64 2.15.3 (2013-03-01)—‘Security Blanket’,
package Survival) to estimate hazard ratios and their
confidence intervals, which correspond to the
chance of being diagnosed at any point within a
given time period relative to controls. When a hazard
function h(t) is dependent on n covariates (x1, x2, . . .,
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Table 1. Base-line statistics, including means with SDs in brackets for all continuous variables, and ab-
solute numbers with percentages in brackets for all categorical variables that were controlled for in the Model
1 (Fig. 2) and Model 2 + 3 (Fig. 3) analyses of the effects of exposure to mild and severe pre-eclampsia on
child morbidity
Variables Normotensive pregnancies Pre-eclampsia pregnancies
Degree of pre-eclampsia Unexposed Mild Severe
Sample size (N) 704 013 23 920 4551
Maternal variables
Age at delivery (SD) 28.6 (4.6) 27.7 (5.1) 28.0 (5.0)
Parity N (%)
1 340 947 (48.4) 15 307 (64.0) 3192 (70.1)
2 267 079 (37.9) 5916 (24.7) 930 (20.4)
>3 95 977 (13.6) 2697 (11.3) 429 (9.4)
Education N (%)
Primary education (10–12 years) 31 246 (4.4) 1360 (5.7) 241 (5.3)
Secondary education (12–15 years) 114 992 (16.3) 5365 (22.4) 906 (19.9)
Professional education 283 038 (40.2) 10 111 (42.3) 1929 (42.4)
B.Sc degree 215 401 (30.6) 5917 (24.7) 1210 (26.6)
M.Sc degree 56 003 (8.0) 1112 (4.7) 250 (5.5)
22+ years of education 3333 (0.5) 55 (0.2) 15 (0.3)
Paternal variables
Age at delivery (SD) 31.3 (5.6) 30.4 (5.9) 30.7 (6.0)
Offspring variables
Male N (%) 360 591 (51.2) 12 554 (52.5) 2363 (51.9)
Female N (%) 343 422 (48.8) 11 366 (47.5) 2188 (48.1)
Ponderal index adjusted for gestational age (SD) 14.40 (2.0) 14.36 (2.1) 13.60 (1.9)
Gestation age, days (SD) 279.3 (10.8) 276.7 (11.7) 258.5 (22.7)
Mean birth length, cm (SD) 52.1 (2.4) 51.8 (2.7) 48.5 (4.7)
Mean birth weight, gram (SD) 3544 (508.6) 3469 (607.1) 2753 (875.4)
Z-score (%) males/femalesa
Z  2 2.3/2.4 5.3/5.2 3.3/2.7
2 > Z 1 12.4/12.9 14.5/13.4 8.9/6.9
1 < Z< 1 71.2/71.1 60.0/59.3 47.3/42.6
1 > Z2 11.6/11.2 15.2/17.1 25.4/28.0
Z2 2.5/2.3 5.1/5.0 15.2/19.8
Mean birth year 1995 1992 1994
Mean age at being diagnosed (years)b
Infections 4.8 (0–6) 5.6 (0–8) 3.8 (0–5)
Neoplasm 11.4 (3–18) 13.0 (6–20) 10.0 (1–16)
Blood 6.6 (1–10) 7.1 (0–12) 5.4 (0–8)
Endocrine 9.2 (1–16) 11.1 (1–21) 6.8 (0–12)
Behavior 12.8 (6–18) 13.6 (8–19) 11.7 (5–17)
Nervous system 9.0 (2–14) 10.2 (2–17) 8.1 (1–13)
Eye/ear 5.1 (1–7) 5.7 (1–8) 4.6 (0–6)
Circulatory 13.1 (5–20) 15.6 (9–22) 12.3 (4–20)
Respiratory 4.1 (0–5) 4.9 (1–7) 4.0 (0–5)
Digestive system 8.6 (2–14) 9.6 (2–16) 6.9 (0–12)
Skin 8.8 (2–15) 10.6 (2–18) 9.2 (2–16)
(continued)
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xn), where the effect is measured by the size of the
respective coefficients (b1, b2, . . ., bn), its mathem-
atical expression becomes h(t) = h0(t) exp
b1x1 + b2x2 + . . . + byxy. Thus, h(t) is the probability
(relative to controls) that an offspring at time t is
diagnosed with a disease within one of the 14 dis-
ease groups. The changeover between ICD-8 and
ICD-10 coding did not affect the diagnostic criteria,
but the easier ICD-10 registration method increased
the number of reported diagnoses. To compensate
for this effect, we added the covariate ‘year’ to all our
analyses to substantiate the general assumption
that overall hazards remained constant through
time.
We used three models based on Cox proportional-
hazard regression. Model 1 is a combined analysis
where both women with mild and severe pre-
eclampsia were included, whereas models 2 and 3
are comparable multivariate analyses focusing on
women with mild pre-eclampsia and women with
severe pre-eclampsia, separately. The combined
Model 1 analysis of hazard ratios associated with
exposure to mild and severe pre-eclampsia partialed
out the covariates maternal and paternal age at de-
livery, parity (first, second or third and above third
birth), maternal education (primary, secondary, pro-
fessional, B.Sc, M.Sc or above), sex of the child
(male: 0/female: 1), number of days of pre-
eclampsia (observed range 1–120; calculated from
first day of diagnosis to delivery), year of delivery (to
reduce noise from changes in total number of diag-
noses—see above) and ponderal index (birth
weight/(birth length3)) adjusted for gestational age
(birth weight cut-offs 200 and 6500 g). For birth
weight, Z-scores (birth weight—mean/SD) were
calculated based on the national reference intrauter-
ine growth curve for Denmark and are presented
separately as these are often used in perinatological
practices [30].
The two additional Cox regression analyses
(Models 2 and 3) tested the extent to which child
morbidity was affected by the duration of exposure
to either mild or severe pre-eclampsia, because
these separate effects have not previously been
analysed. All covariates specified above for the
Model 1 analysis were also included in the Model 2
and 3 analyses. We present the effects of exposure
duration for mild and severe pre-eclampsia side-by-
side to facilitate comparison, but the effects of the
other covariates only for the combined Model 1 ana-
lysis as these effects remained very similar in the two
additional models.
P-values were adjusted for multiple testing by FDR
and we tested for homogeneity of variances for the haz-
ard ratio response variables in each of the five classes of
gestational age. There were no significant deviations
from homogeneity, neither in the Model 1 analysis
(mild PE: week 28–33: P= 0.95, week 34–36: P= 0.51,
week 37–38: P= 0.13, week 39–40: P= 0.63, week 41–
44: P= 0.37, severe PE: week 28–33: P= 0.64, week 34–
36:P= 0.20, week 37–38:P= 0.12, week 39–40:P= 0.12,
week 41–44: P= 0.28), nor the Model 2 and 3 analyses
(mild PE: week 28–33: P= 0.09, week 34–36: P= 0.12,
week 37–38: P= 0.13, week 39–40: P= 0.13, week 41–
Table 1. Continued
Variables Normotensive pregnancies Pre-eclampsia pregnancies
Degree of pre-eclampsia Unexposed Mild Severe
Musculoskeletal 12.3 (6–18) 13.9 (9–19) 13.0 (8–18)
Genitourinary 11.1 (4–18) 12.4 (4–20) 10.5 (3–18)
Malformations 3.8 (0–6) 4.3 (0–7) 3.2 (0–5)
Gestation length categories N (%)
Week 20–27 (391) 324 (0.1) 3 (0.01) 48 (1.1)
Week 28–33 (4663) 3539 (0.7) 181 (0.8) 683 (15.0)
Week 34–36 (20 249) 17 460 (2.9) 955 (4.0) 994 (21.8)
Week 37–38 (102 459) 92 859 (14.6) 4669 (19.5) 1203 (26.4)
Week 39–40 (410 475) 384 830 (58.3) 12 356 (51.7) 1206 (26.5)
Week 41–44 (217 056) 204 867 (30.8) 5753 (24.1) 352 (0.7)
aFor birth weight, Z-scores (describing the distribution in standard deviations from the mean) were calculated based on the Danish reference growth
curve [30].
bMean age at diagnosis is given in years with first and third quartiles in brackets.
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44: P= 0.47; severe PE: week 28–33: P= 0.06, week 34–
36:P= 0.52, week 37–38:P= 0.07, week 39–40:P= 0.23,
week 41–44: P= 0.50), which allowed comparison of
the 14 disease groups across the 5 gestational age
categories.
To elucidate overall morbidity risks of exposure to
mild or severe pre-eclampsia, we performed Z-trans-
formed combined probability tests with and without
weighted sample sizes (R package survcomp 1.1.6)
using the disease specific P-values. The weighted
and unweighted samples sizes produced almost
identical results, so we only report the former.
Absolute risks of being diagnosed with diseases
after exposure to either mild or severe pre-
eclampsia, compared to the unexposed controls,
were also calculated per gestation category and
evaluated for differences with Mann–Whitney U
tests using P< 0.05 as significance threshold.
Model diagnostics and standard tests (based on
Schoenfeld residuals) were performed in all ana-
lyses to check for violation of the Cox propor-
tional-hazard regressions. No covariates showed
any significant tendencies towards non-linearity.
We report means ± SD for a set of maternal and
paternal covariates that potentially affect the inci-
dence of mild or severe pre-eclampsia diagnoses
and for a set of offspring response variables that
are potentially affected by these maternal diagnoses.
We then evaluate hazard ratios for child morbidity,
again separately for exposure to either mild or severe
pre-eclampsia and for the five (pre- to post-term)
gestational age categories. We further evaluate the
differential effects per disease and gestational age
category for three offspring covariates (birth year,
sex and ponderal index), four parental covariates
(parity, father’s age, mother’s age and maternal edu-
cation) and for the duration of exposure to pre-
eclampsia, always comparing pre-eclampsia diag-
noses with unexposed control pregnancies. Finally,
we assess the isolated effect of duration of exposure
to mild and severe pre-eclampsia (models 2 and 3)
after partialing out the same set of covariates report-
ing the hazard ratio per day of exposure per disease
class per gestational age category.
RESULTS
Child morbidity after exposure to maternal pre-
eclampsia
Week 34–36 was a turning point where mild pre-
eclampsia became the more prevalent diagnosis at
delivery after severe pre-eclampsia was the more
common diagnosis in earlier deliveries (Fig. 1).
Women diagnosed with any form of pre-eclampsia
were younger (unexposed vs. mild PE: F1,
727931 =932, P< 0.0001; unexposed vs. severe PE:
F1, 708562 =86.25, P< 0.0001), had lower parity (un-
exposed vs. mild PE: F1, 727921 =1097, P< 0.0001,
unexposed vs. severe PE: F1, 708552 =484.2,
P< 0.0001), and had fewer years of education (un-
exposed vs. mild PE: F1, 727931 =1151, P< 0.0001,
unexposed vs. severe PE: F1, 708562 =101.6,
P< 0.0001). Also the fathers were younger when a
pregnancy was affected by pre-eclampsia (unex-
posed vs. mild PE: F1, 727931 =592, P< 0.0001,
20-27 28-33 34-36 37-38 39-40 41-44
0
5
10
15
Gestation weeks
mild preeclampsia
severe preeclampsia
Pe
rc
en
t
Figure 1. Percentages of Danish women with mild pre-eclampsia (open dots) or severe pre-eclampsia (black dots) diagnoses
across the six time windows of delivery used in our analyses
See Table 1 for sample sizes for both disorders
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unexposed vs. severe PE: F1, 708562 =65.79,
P< 0.0001) (Table 1).
Among the perinatal variables, the ponderal
index of newborns adjusted for gestational age
was slightly reduced after mild pre-eclampsia (un-
exposed vs. mild PE: F1, 727907 = 12.5, P = 0.0004)
and substantially reduced after severe pre-
eclampsia (unexposed vs. severe PE: F1,
708538 = 810.7, P< 0.0001) compared to children
that were not exposed to pre-eclampsia (Table 1).
The Z-scores for birth weight showed an excess of
children 1–2 SD below average relative to unex-
posed children when mothers had been diagnosed
with severe pre-eclampsia and more of these chil-
dren were born prematurely, marginally so for mild
pre-eclampsia (unexposed vs. mild PE: F1,
727931 = 1358, P< 0.0001) and by ca. 3 weeks for se-
vere pre-eclampsia (unexposed vs. severe PE: F1,
708562 = 16 355, P< 0.0001) (Table 1). Further ana-
lysis of the seven covariates (see Supplementary
Table S2) showed that: (i) A higher ponderal index
is consistently associated with reduced morbidity
in preterm and early term children. (ii) Boys tend to
be more sensitive to neoplasm, endocrine and
musculoskeletal disorders and girls to most other
disease categories. (iii) As far as parity had a sig-
nificant effect, later children tended to have slightly
better health (reduced morbidities). (iv) Effects of
paternal age were consistently non-significant, but
older mothers (v) had slightly healthier children.
(vi) A higher level of combined parental education
was consistently associated with reduced child
morbidity. (vii) As expected due to increases in
number of diagnoses over the years, birth year sig-
nificantly increased risk of being diagnosed.
Offspring morbidity hazard ratios after
pregnancies with either mild or severe pre-
eclampsia were generally enhanced across all deliv-
ery time categories compared to children of non-
hypertensive mothers (Fig. 2, see Supplementary
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Figure 2. Risk (log hazard ratio) of being diagnosed up to 30 years after birth in each of the 14 disease groups (legend at the
bottom right) for children born to mothers with either mild or severe pre-eclampsia (PE), relative to unexposed children born to
normotensive mothers
Logged hazard ratios represent increased (above 0) or decreased (below 0) risks. See Supplementary Table S5 for confidence
limits. The gestation time period of 20–27 weeks was excluded due to low sample sizes (see text and Table 1 for details)
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Table S3), which was reflected in the combined P-
values analysis, where only week 28–33 for mild and
severe pre-eclampsia and week 34–36 for se-
vere pre-eclampsia remained non-significant.
Absolute risk estimates showed higher risks across
all gestation categories when exposed to mild or
severe pre-eclampsia compared to unexposed chil-
dren. Children exposed to mild pre-eclampsia ap-
peared to have consistently higher absolute risks
than children exposed to severe pre-eclampsia,
but this was only (marginally) significant for week
28–33 (U = 52, Z-score = 2.09, P = 0.04) and week
39–40 (U = 53, Z-score = 2.04, P = 0.04) (see
Supplementary Table S4). The results for children
born after mild or severe pre-eclampsia in the
gestational age category of 28–33 and 34–36 weeks
were less informative due to the smaller sam-
ple sizes (Table 1), but there appeared to be no
difference in the magnitude of effects (bar heights
in Fig. 2) across the last three delivery categories
(>36 weeks) where sample sizes were larger.
Neither did we find substantial differences be-
tween hazard ratios associated with mild and se-
vere pre-eclampsia for the final three delivery
categories, so the lower number of significant dis-
order-specific hazard ratios for severe pre-
eclampsia can likely be attributed to the ca. five
times lower sample sizes than for mild pre-
eclampsia (Table 1).
The average ages of being diagnosed within the 14
main disease groups are concentrated in childhood
and early adolescence, both for unexposed children
and for children exposed to mild or severe pre-
eclampsia (see Table 1 and Supplementary Fig.
S1), indicating that our follow-up time was generally
sufficient to capture the important effects.
Increased child morbidity associated with
duration of exposure to pre-eclampsia
We found consistently increased risks per day of
exposure to mild and severe pre-eclampsia (Fig. 3,
see Supplementary Table S5), suggesting that ex-
posure duration increases general morbidity during
childhood and adolescence across most disease
groups (also here the very preterm category of 28–
33 weeks gestation is less informative for the mild
pre-eclampsia pregnancies). Exposure to severe
pre-eclampsia significantly increased relative risk
of being diagnosed for almost all disease groups
after week 37, whereas exposure to mild pre-
eclampsia was associated with more modestly
increased risks. Hazard ratios were above one in
12 out of 14 disease groups for deliveries at 34–36
weeks, in 13 of the 14 disease groups for deliveries
in week 37–38 and week 39–40 and in 11 out of
14 disease groups for deliveries in week 41–44;
respective overall significances P = 0.003,<0.001,
0.02 and 0.02 (Fig. 3). All but one (neoplasm in week
34–36) of the disease-specific P-values became
non-significant after FDR adjustment, illustrating
that an overall pattern across diseases can be strik-
ingly consistent even though the composing dis-
ease-specific differences mostly fail to reach
significance when considered in isolation. As
aforementioned, the results presented in Fig. 3
(see Supplementary Table S5) were adjusted for
all potentially confounding variables listed in
Table 1.
Analysing the specific effects of exposure to
mild pre-eclampsia
Focusing on specific disease groups where a mild pre-
eclampsia diagnosis both had a significant effect on
general child morbidity (Fig. 2) and where the effect
increased per day of exposure (Fig. 3, see
Supplementary Table S5), the following results ap-
peared to be most striking. First, children delivered
preterm (gestation 34–36 weeks) had an increased
risk of endocrine disorders (HR 1.48; 95% CI 1.17–
1.87) compared to normotensive pregnancies (Fig. 2,
see Supplementary Table S3), and the magnitude of
this effect increased with days between diagnosis and
delivery (HR 1.01; 95% CI 1.00–1.01) (Fig. 3, see
Supplementary Table S5). Second, children delivered
early term (gestation 37–38 weeks) had a significantly
increased overall risk of mental and behavioral dis-
orders (HR 1.19; 95% CI 1.04–1.37) and infections
including parasites (HR 1.26; 95% CI 1.16–1.36)
compared to normotensive controls (Fig. 2, see
Supplementary Table S3) and also these risks
increased significantly with days between diagnosis
and delivery (HR 1.006; 1.001–1.011 and HR 1.003;
1.000–1.006, respectively) (Fig. 3, see Supplementary
Table S5). Third, term-delivered children (gestation
39–40 weeks) had a significantly increased overall risk
of eye/ear and adnexa disorders (HR 1.19; 95% CI
1.13–1.26) and respiratory system diseases (HR
1.25; 95% CI 1.21–1.30) compared to normotensive
controls (Fig. 2, see Supplementary Table S3) and
both these risks increased significantly with days be-
tween diagnosis and delivery (HR 1.004; 1.001–1.007
and HR 1.003; 1.000–1.005, respectively) (Fig. 3, see
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Supplementary Table S5). A similar double effect was
found in post-term deliveries (gestation 41–44 weeks)
for congenital malformations (HR 1.11; 95% CI 1.02–
1.21 as main effect and duration of exposure as add-
itional effect (HR 1.006; 1.001–1.011) (Fig. 3, see
Supplementary Table S5).
DISCUSSION
The novelty and confirmative nature of our
findings
To our knowledge, this is the first large-scale public
health study on long-term morbidity in children
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Figure 3. The effect of days of exposure to mild or severe pre-eclampsia (PE) after adjustment for categorical effects (diagnosis
or not) and potentially confounding predictor variables (Table 1 and see Supplementary Table S2) on hazard ratios of child
morbidity in five categories of gestational age, based on up to 30 years of follow-up
Significant hazard ratios (HR) and their confidence intervals (CI) are plotted in red, but for mild pre-eclampsia all became non-
significant after FDR adjustment, except for the neoplasm effect in week 34–36. For severe pre-eclampsia only digestive and
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associated with maternal diagnoses of pre-eclampsia
and of the additional effects of duration of fetal ex-
posure to pre-eclampsia. After conservative FDR ad-
justments, our results indicate significantly enhanced
hazard ratios in the order of 10–25% for a series of
disorders (Fig. 2, see Supplementary Table S3), with
further increases in the order of 0.3–1.2% for every
day of additional exposure to mild pre-eclampsia
(Fig. 3). The effects outlined in the final paragraph
of the results section could be ‘tips of icebergs’, be-
cause many similar but weaker trends were observed
for other diseases, which were only significant when
pooling effects across the 14 disease categories (Fig.
3, see Supplementary Table S5).
Our evaluation of the absolute risks point in the
same direction as the risk patterns obtained from
the hazard ratios showing consistently higher
relative risk of morbidity across disease categories
when exposed to either mild or severe pre-eclampsia
compared to the unexposed group (Fig. 2, see
Supplementary Table S4). The trends in hazard
ratios are very similar when evaluating days of ex-
posure (Fig. 3), a result that appears to justify
pooling all pre-eclampsia diagnoses. However, this
inference could only be obtained by doing the ana-
lyses separately as we have done here for the first
time. The effects of severe pre-eclampsia are more
likely to be statistically significant on a case-by-case
basis in spite of the smaller sample sizes, but the
effects of mild pre-eclampsia on morbidity later in
life can apparently not be ignored, especially be-
cause duration of exposure (number of days
diagnosed with the disease until delivery) is often
longer than days exposed to severe pre-eclampsia.
This underlines that possible long-term effects of
exposure to mild pre-eclampsia deserve more spe-
cific study and clinical consideration because it is the
more common disorder of the two.
Our results add relevant detail to a previous
Danish registry study, which demonstrated
increased morbidity in children up to three decades
after pooled pre-eclampsia pregnancies [31]. That
study specifically highlighted enhanced risks of
endocrine, nutritional and metabolic diseases,
which are all part of the metabolic syndrome that
increases risks of cardiovascular diseases later in
life. Our present results corroborate these earlier
findings and suggests that part of these morbidity
effects are associated with the duration of exposure.
The statistical effects of covariates that we un-
covered largely confirmed previous insights for ef-
fects of ponderal index [30, 32] and education [33],
and the tendency that older mothers have healthier
children (see Supplementary Table S2) has also pre-
viously been documented [34]. As far as we
evaluated the effects of severe and mild pre-
eclampsia, we also confirmed known cumulative ef-
fects on size at birth [35].
The relevance of the evolutionarily perspective
Pre-eclampsia has been described as ‘the disease of
theories’ because its etiology has remained elusive.
As we explained in the introduction, the enigmatic
existence of the disorder may ultimately be due to an
imbalanced resolution of evolutionarily conflict be-
tween patrigenic (padumnal) and matrigenic
(madumnal) effects on fetal provisioning [12, 16,
17, 24], with pre-eclampsia as a collateral damage
byproduct. The rationale would then be that the ex-
pression of conflict by itself increases the probability
of offspring attaining above average health, but that
this favorable outcome is conditional on a controlled
balance between paternal and maternal provision-
ing being reached early in gestation, because less
common unbalanced outcomes are clearly patho-
logical [24].
The alternative ultimate hypothesis driven by the
need to sustain early human brain development [11,
12] and the necessity for inflammation signals dur-
ing implantation to be balanced according to the
Goldilock Principle [10] is less general and inconsist-
ent with pre-eclampsia also occurring in great apes
[13, 14]. Chimpanzee pre-eclampsia does not, how-
ever, compromise the parental antagonism hypoth-
esis as promiscuity in our closest primate relatives is
higher than in humans [36]. If the continued exist-
ence of pre-eclampsia is indeed driven by factors
that depend on the combination of maternal and
paternal genes rather than on maternal genes only,
an important implication of our present and previ-
ous study [24] might be that searching for a heritable
component (maternal genes pre-exposing to pre-
eclampsia) is unlikely to be successful.
Proximate mechanisms mediating pre-
eclampsia and the clinical relevance of our
results
It has recently been suggested that pre-eclampsia
may be mitigated by the peripheral T regulatory cells
(pTreg) that evolved to provide a stronger maternal-
fetal tolerance in placental mammals [37]. As pre-
eclampsia always involves elevated maternal blood
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pressure, it is interesting that children of mildly pre-
eclamptic mothers have substantially increased
risks of endocrine disorders, including diabetes
and developing elevated blood pressure problems
themselves later in life [31, 38]. The extent to which
these effects could be due to recent changes in
human life-style remains to be investigated.
It is known that the mild pre-eclampsia syndrome
may be recurrent across pregnancies of the same
women with negative implications such as fetal
growth restriction and placental abruption [7],
comorbidities that often dictate expeditious delivery
because they are known to be associated with
increased child morbidity [39]. Prematurity per se is
also linked to later learning difficulties in basic
school (age 6–15) and risk of not completing an
education [40], so exposure to pre-eclampsia
combined with fetal growth restriction is a known
aggravating factor with respect to later performance
parameters [41].
The organ systems most sensitive to mild pre-
eclampsia exposure appear to be the neurological
system, eyes and ears and the respiratory system
(Figs 2 and 3, see Supplementary Tables S3 and
S5). The respiratory system effect has previously
been linked to caesarean sections [42], which could
confound our inferences for these risks as
caesarean sections are more common for pre-
eclampsia deliveries [43]. The neurological effects
may be associated with the diagnosed mental and
behavioral disorders and with retinopathy [44], for
which we found exposure duration effects in early-
term deliveries (Fig. 3). These aspects would bene-
fit from further investigations into specific diag-
noses to disentangle where the highest risks
present themselves, because these details remain
unresolved in the grouped diagnoses of our present
study.
For clinical practice our results imply that the
management of mild pre-eclampsia by expeditious
delivery after 37 weeks may reduce life-time morbid-
ity while also preventing progression of maternal
perinatal disease—inferences that appear to match
the results from the seminal HYPITAT trial [4] (but
see below for some caveats). The gradual build-up of
these later morbidity risks from gestation weeks 34–
36 onwards thus suggests that future health pro-
spects of newborns should become part of the clin-
ical management of pre-eclampsia from at least 37–
38 weeks gestation and possibly earlier (week 34–
36) (Fig. 1).
Caveats
Because of the large sample sizes, our cohort study
based on a complete census of all live births and
subsequent medical diagnoses in Denmark during
three decades allowed for sufficient statistical power
to detect small effects. As hospitalizations are most
common before age 10 and after age 45 (except for
pregnancy-related reasons and deliveries [45]) and
our data confirmed that diagnoses are concentrated
in childhood and early adolescence for all disease
groups (Table 1, see Supplementary Fig. S1), we be-
lieve that the follow-up of 4–30 years that was avail-
able to us should generally have been appropriate for
assessing the morbidity consequences of exposure
to pre-eclampsia. However, we realize that this fol-
low-up time remains less than ideal for metabolic
syndromes as these tend to be diagnosed later in
life than behavioral and mental disorders [28].
Although we could partial out more potentially
confounding effects than most other public health
studies, we had no data on maternal body mass
index and smoking, factors that have previously
been shown to increase the risk of pre-eclampsia
[46], and we did not know which children had been
born after C-section (see Methods). It is important
to note that socioeconomic variables in Denmark
are expected to have smaller effects on general
health than in most other countries, because free
health care is available to all residents and the coun-
try’s GINI coefficient of socioeconomic inequality is
among the lowest in the world [47]. There is a ten-
dency that Danish families of lower socioeconomic
status have a higher degree of encounters with hos-
pitals, while families of higher socioeconomic status
have more encounters with their general practitioner
[45] but this kind of effect tends to account for less
than 1% of the variation in morbidity across the
years included in our study [45]. It would obviously
have been beneficial if effects of diet and life style
could have been included in our analyses, but such
data are not available in the Danish public health
records.
Mostly of clinical relevance, antihypertensive
treatment may itself negatively affect neurocognitive
development of children, as suggested by recent
studies that incriminated all three standard drugs
in Denmark: methyldopa, labetalol and nifedip [48,
49], reviewed in Koren [50]. We did not have infor-
mation on any antihypertensive treatments that may
have been applied, so some of the observed effects
may be due to a combination of pre-eclampsia and
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antihypertensive treatment. No study has yet
disentangled the separate effects of condition and
treatment on these comorbidities.
Finally, we would like to stress that the likelihood
of our results having predictive value for other popu-
lations will depend on the neonatal and general ob-
stetric support available at delivering units. We
therefore expect that our results may be valid for
other affluent societies, but that they are not directly
transferable to developing countries.
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